SCHEDULE 13G/A

Beta Bionics Inc

Common Stock · CUSIP: 08659B102

Event date: 2025-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• Soleus BB SPV, LLC

  Shares: 0.00 · Class: 0.00%

• Soleus Private Equity Fund I, L.P.

  Shares: 0.00 · Class: 0.00%

• Soleus Private Equity GP I, LLC

  Shares: 0.00 · Class: 0.00%

• Soleus PE GP I, LLC

  Shares: 0.00 · Class: 0.00%

• Soleus Private Equity Fund II, L.P.

  Shares: 1,703,961.00 · Class: 3.9%

• Soleus Private Equity GP II, LLC

  Shares: 1,703,961.00 · Class: 3.9%

• Soleus PE GP II, LLC

  Shares: 1,703,961.00 · Class: 3.9%

• Soleus Capital Master Fund, L.P.

  Shares: 799,817.00 · Class: 1.8%

• Soleus Capital, LLC

  Shares: 799,817.00 · Class: 1.8%

• Soleus Capital Group, LLC

  Shares: 799,817.00 · Class: 1.8%

• Soleus Capital Management, L.P.

  Shares: 2,503,778.00 · Class: 5.7%

• Soleus GP, LLC

  Shares: 2,503,778.00 · Class: 5.7%

• Guy Levy

  Shares: 2,534,565.00 · Class: 5.8%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.